128 related articles for article (PubMed ID: 38479270)
61. A review of advanced nanoformulations in phototherapy for cancer therapeutics.
Hak A; Ravasaheb Shinde V; Rengan AK
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102205. PubMed ID: 33561574
[TBL] [Abstract][Full Text] [Related]
62. Singlet Oxygen-Responsive Polymeric Nanomedicine for Light-Controlled Drug Release and Image-Guided Photodynamic-Chemo Combination Therapy.
Yang DC; Wang S; Weng XL; Zhang HX; Liu JY; Lin Z
ACS Appl Mater Interfaces; 2021 Jul; 13(29):33905-33914. PubMed ID: 34278780
[TBL] [Abstract][Full Text] [Related]
63. Improved photodynamic cancer treatment by folate-conjugated polymeric micelles in a KB xenografted animal model.
Syu WJ; Yu HP; Hsu CY; Rajan YC; Hsu YH; Chang YC; Hsieh WY; Wang CH; Lai PS
Small; 2012 Jul; 8(13):2060-9. PubMed ID: 22508664
[TBL] [Abstract][Full Text] [Related]
64. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
65. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
66. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
Wang Y; Shen W; Liang XH; Crooke ST
Nucleic Acid Ther; 2019 Dec; 29(6):343-358. PubMed ID: 31429620
[TBL] [Abstract][Full Text] [Related]
67. Synthesis and Aggregation of a Porphyrin-Cored Hyperbranched Polyglycidol and Its Application as a Macromolecular Photosensitizer for Photodynamic Therapy.
Kadhim A; McKenzie LK; Bryant HE; Twyman LJ
Mol Pharm; 2019 Mar; 16(3):1132-1139. PubMed ID: 30694688
[TBL] [Abstract][Full Text] [Related]
68. Enhancing Photodynamic Therapy Efficacy Against Cancer Metastasis by Ultrasound-Mediated Oxygen Microbubble Destruction to Boost Tumor-Targeted Delivery of Oxygen and Renal-Clearable Photosensitizer Micelles.
Xu Y; Liu R; Yang H; Qu S; Qian L; Dai Z
ACS Appl Mater Interfaces; 2022 Jun; 14(22):25197-25208. PubMed ID: 35615986
[TBL] [Abstract][Full Text] [Related]
69. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy.
Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y
Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647
[TBL] [Abstract][Full Text] [Related]
70. Enzyme-Assisted Photodynamic Therapy Based on Nanomaterials.
Du B; Tung CH
ACS Biomater Sci Eng; 2020 May; 6(5):2506-2517. PubMed ID: 33463268
[TBL] [Abstract][Full Text] [Related]
71. Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin/chlorin e6 for combined chemotherapy and O
Ding YF; Xu X; Li J; Wang Z; Luo J; Mok GSP; Li S; Wang R
Acta Biomater; 2023 Jul; 164():397-406. PubMed ID: 37004784
[TBL] [Abstract][Full Text] [Related]
72. Light-Controlled Simultaneous "On Demand" Release of Cytotoxic Combinations for Bimodal Killing of Cancer Cells.
Tessaro AL; Fraix A; Failla M; Cardile V; Graziano ACE; Estevão BM; Rescifina A; Sortino S
Chemistry; 2018 May; 24(30):7664-7670. PubMed ID: 29603456
[TBL] [Abstract][Full Text] [Related]
73. Synergistic effect of mesoporous silica nanocarrier-assisted photodynamic therapy and anticancer agent activity on lung cancer cells.
Güleryüz B; Işık A; Gülsoy M
Lasers Med Sci; 2024 Mar; 39(1):91. PubMed ID: 38491201
[TBL] [Abstract][Full Text] [Related]
74. Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
Master AM; Livingston M; Oleinick NL; Sen Gupta A
Mol Pharm; 2012 Aug; 9(8):2331-8. PubMed ID: 22775587
[TBL] [Abstract][Full Text] [Related]
75. Dual-light triggered metabolizable nano-micelles for selective tumor-targeted photodynamic/hyperthermia therapy.
Deng Y; Wang X; Liu Y; Xu Y; Zhang J; Huang F; Li B; Miao Y; Sun Y; Li Y
Acta Biomater; 2021 Jan; 119():323-336. PubMed ID: 33122146
[TBL] [Abstract][Full Text] [Related]
76. Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy.
Cheng H; Zheng RR; Fan GL; Fan JH; Zhao LP; Jiang XY; Yang B; Yu XY; Li SY; Zhang XZ
Biomaterials; 2019 Jan; 188():1-11. PubMed ID: 30312907
[TBL] [Abstract][Full Text] [Related]
77. Targeted and Oxygen-Enriched Nanoplatform for Enhanced Photodynamic Therapy: In Vitro 2D Cell and 3D Spheroid Model Evaluation.
Chen CY; Chen CY
Macromol Biosci; 2023 Dec; 23(12):e2300196. PubMed ID: 37565670
[TBL] [Abstract][Full Text] [Related]
78. Sequentially Activatable Polypeptide Nanoparticles for Combinatory Photodynamic Chemotherapy of Breast Cancer.
Zhang H; Pan J; Wang T; Lai Y; Liu X; Chen F; Xu L; Qu X; Hu X; Yu H
ACS Appl Mater Interfaces; 2022 Sep; 14(35):39787-39798. PubMed ID: 36001127
[TBL] [Abstract][Full Text] [Related]
79. Open-Source and Reduced-Expenditure Nanosystem with ROS Self-Amplification and Glutathione Depletion for Simultaneous Augmented Chemodynamic/Photodynamic Therapy.
Chen M; Zhao S; Zhu J; Feng E; Lv F; Chen W; Lv S; Wu Y; Peng X; Song F
ACS Appl Mater Interfaces; 2022 May; 14(18):20682-20692. PubMed ID: 35500204
[TBL] [Abstract][Full Text] [Related]
80. Unprotonatable and ROS-Sensitive Nanocarrier for NIR Spatially Activated siRNA Therapy with Synergistic Drug Effect.
Deng S; Wang S; Xiao Z; Cheng D
Small; 2022 Oct; 18(41):e2203823. PubMed ID: 36094800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
